Cell and Gene Therapies

Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 12, 2018
By BioPharm International Editors
The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
Jan 19, 2018
By BioPharm International Editors
GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.
Jan 12, 2018
By BioPharm International Editors
A new target for the treatment of multiple myeloma using CAR-T technology was discovered by researchers at Osaka University.
Jan 05, 2018
By BioPharm International Editors
The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.
Jan 04, 2018
By BioPharm International Editors
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
Dec 20, 2017
By BioPharm International Editors
FDA has approved a new gene therapy for treating patients born with a rare, inherited vision loss.
Dec 19, 2017
By BioPharm International Editors
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
Dec 19, 2017
By BioPharm International Editors
Sanofi Genzyme and its partner, Alnylam Pharmaceuticals, have filed a marketing authorization application with EMA for an investigational RNAi therapeutic for treating a genetic-based disease.
native1_300x100
lorem ipsum